High-Grade Serous Ovarian Cancer — Trials

High-Grade Serous Ovarian Cancer — Trials · CancerIndex

Clinical trials

Registered studies

28 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 13
Recruiting: 8
Ph III recruiting: 1
Growth YoY: —
Industry share: 46%
Top sponsor: University Health Network, Toronto
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03268382	p53 Activation in Platinum-Resistant High Grade Serous Ovarian Cancer, a Study of PLD With APR-246	completed	Phase 2	36	Aprea TherapeuticsINDUSTRY	3	Mar 17, 2025	clinicaltrials

Data updated 22 days agoSource updated Mar 17, 2025source: clinicaltrials